首页> 外文期刊>生物医学与环境科学(英文版) >Expression of Human Vascular Endothelial Growth FactorrnReceptor Flt-1 Extracellular Domain 1-3 Loop cDNA rnin Pichia pastoris, Purification of the Expressed rnProduct and Detection of Its Biological Activity
【24h】

Expression of Human Vascular Endothelial Growth FactorrnReceptor Flt-1 Extracellular Domain 1-3 Loop cDNA rnin Pichia pastoris, Purification of the Expressed rnProduct and Detection of Its Biological Activity

机译:人血管内皮生长因子受体Flt-1胞外域1-3环cDNA在毕赤酵母中的表达,表达产物的纯化及其生物学活性的检测

获取原文
获取原文并翻译 | 示例
       

摘要

Objective To express human vascular endothelial growth factor receptor Flt-1 extracellular domain 1-3 loop cDNA in Pichia. Pastroris, and to purify the expressed product and detect its biological activity. Methods By inserting human Flt-1 (1-3 loop) cDNA coding 316 amino acid residues into Pichia pastoris expression vector pPIC9K containing AOX1 promoter and the sequences of α secreting signal peptides, a recombinant expression plasmid pPIC9K/Flt-1 (1-3) was constructed and transformed to yeast host strain GS115, then His+ Muts phenotype transformant was screened out and cultured in flasks, and Flt-1 (1-3) was expressed under the induction of 1% methanol. Results SDS-PAGE showed that after being induced with 1% methanol for 4d, the expressed product existed in supernatant in the form of soluble molecule and contained 60% of total protein expressed. Western blot showed good antigenicity and specificity of expressed product. After being purified by CM-Sepharose FF and Sephacryl S-100 chromatography, the purity of the expressed product reached above 90%. Biological assay proved that the expressed product could bind to hVEGF165 and inhibit the proliferation of HUVEC stimulated by hVEGF165. Conclusion Human vascular endothelial growth factor receptor Flt-1 extracellular domain 1-3 loop was successfully expressed. The study lays a foundation for further application of the expressed product in the treatment of vasoformation related diseases, such as tumor and diabetic retinopathy.
机译:目的在毕赤酵母中表达人血管内皮生长因子受体Flt-1胞外域1-3环cDNA。并鉴定出表达的产物并检测其生物学活性。方法通过将编码316个氨基酸残基的人Flt-1(1-3环)cDNA插入含有AOX1启动子和α分泌信号肽序列的毕赤酵母表达载体pPIC9K,重组表达质粒pPIC9K / Flt-1(1-3 )构建并转化到酵母宿主菌株GS115中,然后筛选出His + Muts表型转化体并在烧瓶中培养,并在1%甲醇的诱导下表达Flt-1(1-3)。结果SDS-PAGE分析表明,用1%甲醇诱导4d后,表达产物以可溶性分子的形式存在于上清液中,占表达蛋白总量的60%。 Western印迹显示出良好的抗原性和表达产物的特异性。经CM-Sepharose FF和Sephacryl S-100色谱纯化后,表达产物的纯度达到90%以上。生物学测定证明表达的产物可与hVEGF165结合并抑制hVEGF165刺激的HUVEC的增殖。结论成功表达了人血管内皮生长因子受体Flt-1胞外域1-3环。该研究为表达产物在血管形成相关疾病如肿瘤和糖尿病性视网膜病的治疗中的进一步应用奠定了基础。

著录项

  • 来源
    《生物医学与环境科学(英文版)》 |2001年第4期|292-301|共10页
  • 作者

  • 作者单位

    Institute of Molecular Immunology, The First Military Medical University,;

    Institute of Molecular Immunology, The First Military Medical University,;

    State Key Laboratory of Molecular Virology and Genetic Engineering,;

    State Key Laboratory of Molecular Virology and Genetic Engineering,;

    State Key Laboratory of Molecular Virology and Genetic Engineering,;

    State Key Laboratory of Molecular Virology and Genetic Engineering,;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 生物化学;
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号